Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KRON | Kronos Bio, Inc. | Director | $31.4K | Jun 25, 2024 | ||
KYMR | Kymera Therapeutics, Inc. | Director | Jun 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|